Janiczek Wealth Management, LLC Repligen Corp Transaction History

Janiczek Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$154.26 - $198.1 $6,941 - $8,914	45 New	45 $7,000
Q2 2022 Aug 03, 2022	SELL	$140.68 - $188.02 $3,094 - $4,136	-22 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$161.19 - $257.96 $3,707 - $5,933	-23 Reduced 51.11%	22 $4,000
Q4 2021 Feb 02, 2022	BUY	$247.59 - $304.47 $742 - $913	3 Added 7.14%	45 $12,000
Q3 2021 Oct 19, 2021	BUY	$194.77 - $324.21 $1,558 - $2,593	8 Added 23.53%	42 $12,000
Q2 2021 Jul 28, 2021	SELL	$165.87 - $220.95 $4,810 - $6,407	-29 Reduced 46.03%	34 $7,000
Q1 2021 Apr 28, 2021	SELL	$180.37 - $226.26 $18,397 - $23,078	-102 Reduced 61.82%	63 $12,000
Q4 2020 Jan 26, 2021	BUY	$148.08 - $206.57 $21,323 - $29,746	144 Added 685.71%	165 $32,000
Q3 2020 Oct 19, 2020	BUY	$122.51 - $158.27 $2,572 - $3,323	21 New	21 $3,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.